Javascript must be enabled to continue!
From p-values to Bayes Factor: A Meta-Analytic Comparison in Colorectal Research
View through CrossRef
Abstract
The prevalent method for synthesizing evidence from multiple studies is the frequentist meta-analysis, which relies on assumptions of long-term frequencies and does not directly address the probability of hypotheses. In contrast, the Bayesian meta-analysis provides a framework that integrates prior knowledge with observed data, offering a more nuanced interpretation. This study aims to compare the outputs and interpretations of frequentist and Bayesian meta-analyses using published trials on colorectal anastomosis as examples. Two previously published meta-analyses on colorectal anastomosis—one evaluating trans-anastomotic tubes (TAT) and the other indocyanine green (ICG) fluorescence imaging—were reanalysed using frequentist and Bayesian approaches. Sequential Bayesian analyses were also conducted, updating priors with each additional study. Results were presented using odds ratios (OR), confidence intervals (CI), credible intervals (CrI), p-values, and Bayes factors (BF10). Both methods produced nearly similar ORs for the TAT meta-analysis; however, the Bayesian approach yielded slightly narrower CrIs and a BF10 that indicated a slight preference for the null hypothesis that was unclear with p-values alone. In the ICG meta-analysis, the Bayesian analysis produced a BF10 suggesting that it was 19 times more likely to observe the data under the assumption that the alternative hypothesis is true compared to the null, considerably making the estimates more conservative than the frequentist output. The Bayesian sequential analysis demonstrated increasing confidence in the alternate hypothesis with the addition of more studies. While frequentist and Bayesian meta-analyses may produce similar point estimates based on prior evidence, their interpretations and implications for hypothesis testing differ significantly. Bayesian methods offer a more flexible and intuitive approach, particularly in contexts with prior knowledge or when sequential updating is required. While frequentist outputs depend on multiple experiments, assuming that the null is true, and heavy dependence on conventional p-value thresholds, Bayesian outputs provide the direct probability of the hypothesis in question and credible intervals that are likely to contain the true estimate.
Title: From p-values to Bayes Factor: A Meta-Analytic Comparison in Colorectal Research
Description:
Abstract
The prevalent method for synthesizing evidence from multiple studies is the frequentist meta-analysis, which relies on assumptions of long-term frequencies and does not directly address the probability of hypotheses.
In contrast, the Bayesian meta-analysis provides a framework that integrates prior knowledge with observed data, offering a more nuanced interpretation.
This study aims to compare the outputs and interpretations of frequentist and Bayesian meta-analyses using published trials on colorectal anastomosis as examples.
Two previously published meta-analyses on colorectal anastomosis—one evaluating trans-anastomotic tubes (TAT) and the other indocyanine green (ICG) fluorescence imaging—were reanalysed using frequentist and Bayesian approaches.
Sequential Bayesian analyses were also conducted, updating priors with each additional study.
Results were presented using odds ratios (OR), confidence intervals (CI), credible intervals (CrI), p-values, and Bayes factors (BF10).
Both methods produced nearly similar ORs for the TAT meta-analysis; however, the Bayesian approach yielded slightly narrower CrIs and a BF10 that indicated a slight preference for the null hypothesis that was unclear with p-values alone.
In the ICG meta-analysis, the Bayesian analysis produced a BF10 suggesting that it was 19 times more likely to observe the data under the assumption that the alternative hypothesis is true compared to the null, considerably making the estimates more conservative than the frequentist output.
The Bayesian sequential analysis demonstrated increasing confidence in the alternate hypothesis with the addition of more studies.
While frequentist and Bayesian meta-analyses may produce similar point estimates based on prior evidence, their interpretations and implications for hypothesis testing differ significantly.
Bayesian methods offer a more flexible and intuitive approach, particularly in contexts with prior knowledge or when sequential updating is required.
While frequentist outputs depend on multiple experiments, assuming that the null is true, and heavy dependence on conventional p-value thresholds, Bayesian outputs provide the direct probability of the hypothesis in question and credible intervals that are likely to contain the true estimate.
Related Results
What is Analytic Philosophy
What is Analytic Philosophy
Special Issue: What is Analytic PhilosophyReferencesHaaparantaG. P. Baker and P. M. S. Hacker. Frege: Logical Excavations. Oxford, Blackwell, 1984.M. Dummett. The Interpretation of...
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
<p><em><span class="markedContent"><span style="left: calc(var(--scale-factor)*195.53px); top: calc(var(--scale-factor)*496.87px); font-size: calc(var(--scale-...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
<em><span id="page3R_mcid52" class="markedContent"><span style="left: calc(var(--scale-factor)*125.30px); top: calc(var(--scale-factor)*539.11px); font-size: calc(va...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Immunohistochemistry expression of TCF4 protein on carcinoma, adenoma and non neoplastic colorectal mucosa
Immunohistochemistry expression of TCF4 protein on carcinoma, adenoma and non neoplastic colorectal mucosa
AbstractPurpose To detect and quantify the immunoreactivity of TCF4 protein in colorectal carcinoma, colorectal adenoma and non-neoplasic colorectal epithelium.Methods We studied 1...

